Home » Topics » BioWorld Science

BioWorld Science
RSS

Seoul National University Hospital patents triglyceride-lowering peptides

March 29, 2022

LG Chem discovers diacylglycerol O-acyltransferase 2 inhibitors

March 29, 2022

New monoglyceride lipase inhibitors identified at Roche

March 29, 2022

Missense variants in DDX39B linked to novel syndrome of global neurodevelopmental delay

March 28, 2022

Sosei Heptares' GLP-1/2 agonist HTL-0030023 shows promising results for treating NAFLD and NASH

March 28, 2022

Novartis details discovery, preclinical data of novel antimalarial compound INE-963

March 28, 2022

Novel USP30 inhibitors as potential anti-Parkinson candidates

March 28, 2022

Bayer patents P2X purinoceptor 4 antagonists

March 28, 2022

Dompe Farmaceutici describes new peptides with angiogenic activity

March 28, 2022

HDAC inhibitors disovered at Chong Kun Dang Pharmaceutical

March 28, 2022

Popular Stories

Today's news in brief
BioWorld
BioWorld briefs for April 24, 2026.
A free gene therapy? Regeneron’s Otarmeni approved for hearing loss
BioWorld
Children and adults with a type of congenital hearing loss now have a free treatment option, with the U.S. FDA’s accelerated approval of Regeneron Pharmaceuticals...
Detecting the invisible: minimal residual disease at AACR 2026
BioWorld Science
Minimal residual disease (MRD) has become a central concept in modern oncology, reshaping how clinicians evaluate response, relapse risk and treatment precision....
At AACR: Epigenetic fingerprints in metastases track tumor origin
BioWorld
When a tumor migrates and colonizes another tissue or organ, it can be identified as a metastasis, but its origin is not always clear. Now, a study based on...
AACR 2026: The age of agentic AI in oncology
BioWorld Science
New Approach Methodologies (NAMs) for drug development are transforming biomedical research by replacing or complementing animal models. More than 90% of...